Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double Blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients

NCT07650227 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT07650227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07650227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double Blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Recruiting
Start date
December 9, 2025
Completion date
December 31, 2028
Enrollment
308 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

acute bronchitis, bronchitis